CEACAM5 and colorectal carcinoma: The discovered promising candidates were then validated with serum samples of CRC, including early and late stages; the cancer samples were tested side by side with benign disease and healthy controls and compared with conventional CEA, CA19-9, and CA125 immunoassays.